secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtriCure, Inc. (ATRC)
CIK:        0001323885
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001323885-23-000053
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 2023 equity plan and ESPP increase by 750K shares
----------------------------------------------------------------------

- 2023 Stock Incentive Plan approved with 38.1M for, 2.3M against, 28K abstain.
- ESPP amendment approved, increasing authorized shares by 750,000; votes 40.3M for.
- All eight director nominees elected with majority votes (e.g., Michael Carrel 38.7M for).
- Deloitte & Touche ratified as independent auditor for FY2023 (42.1M for).
- Say-on-pay advisory vote passed with 33.7M for, 6.6M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1323885/000132388523000053/0001323885-23-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1323885/000132388523000053/atrc-20230525.htm
  HTML page:      https://secwatch.observer/filing/0001323885-23-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer